ONLINE APPENDIX. The Lives Saved Tool (LiST) (Version 4.2 Beta 7) was used to. project the number of child deaths that would be averted between

Size: px
Start display at page:

Download "ONLINE APPENDIX. The Lives Saved Tool (LiST) (Version 4.2 Beta 7) was used to. project the number of child deaths that would be averted between"

Transcription

1 Stack ML, Ozawa S, Bishai DM, Mirelman A, Tam Y, Niessen, et al. Estimated economic benefits during the Decade of Vaccines include treatment savings, gains in labor productivity. Health Aff (Millwood). 2011;30(6): ONLINE APPENDIX Additional Methods Lives Saved Tool Analysis The Lives Saved Tool (LiST) (Version 4.2 Beta 7) was used to project the number of child deaths that would be averted between the years due to vaccine scale-up (coverage assumptions below). These projections can be seen in Exhibit F. LiST models the impact of health interventions by applying the change in intervention coverage and effectiveness to countryspecific cause-specific mortality, assuming country-specific population growth. Each child can be saved from a given cause only once, but then has the population risk of dying of other causes in subsequent age categories. The underlying burden of disease modeling used to determine the number of deaths averted due to each vaccine is based on extensive data over a large number of countries and up to 20 years of observations, allowing it to capture and mitigate underlying seasonality and annual variation of disease incidence. In the analysis, vaccination coverage levels in 2010 were taken from WHO/UNICEF 2009 estimates of national immunization coverage(1). Countries with vaccination coverage above 90% were 1

2 held constant through For each country, we used WHO published estimates of the numbers of deaths in 2008 due to each disease for children under five years old(2). The effectiveness of Hib, pneumococcal, measles, and rotavirus vaccines used for the analysis was published(3, 4, 5). The effectiveness of DTP vaccine was estimated to be 85%. LiST also estimated yearly deaths due to malaria in children under five years of age. This number was then used to calculate the number of lives saved due to increased coverage of a malaria vaccine. With 45% efficacy(6), a vaccine against malaria was assumed to be introduced in all malaria-affected countries in 2015 with coverage increasing to 90% by Economic Analysis Treatment costs averted Case fatality ratios (CFR) were used to calculate the number of cases that would be averted from the projected number of averted deaths. Country-specific CFRs were applied to project pneumonia and meningitis cases averted. Due to lack of available data, a single CFR was used for all countries except India to calculate cases of measles, malaria, pertussis and rotavirus. A surveillance based case fatality ratio for rotavirus in India was available in the literature and on account of its size and impact on our analysis it was used for India only. All other 2

3 case fatality ratios were estimated from an extensive literature review of surveillance studies in developing countries. The estimates and their uncertainty ranges can be seen in Exhibit G. To calculate the treatment costs averted, care seeking behavior was then applied to the estimated number of averted cases to determine how many cases would have sought care and encountered expenses. Country and symptom-specific care seeking behavior data were gathered from Demographic Health Surveys and UNICEF s State of the World s Children Report (depending on symptom) when available(7, 8). For countries that did not have data, the median of countries with data in the same sub-region was used. The rate of hospitalization depending on severity of disease was then applied to determine how many averted cases who sought care would have been admitted and how many would have been outpatients. Finally, population rates on if outpatients seek care from health centers or hospitals were applied to determine how many outpatients would have been treated in each type of facility. The cost of care was calculated using country-specific WHO- CHOICE estimates for hospital and outpatient fees (9), average bed days per hospitalization by syndrome (10-14) and a proportion of visit costs for medication and diagnostics based on studies from 10 countries (10, 14, 15). These were then 3

4 multiplied by the number of averted cases that would have sought treatment from each facility and the number who would have been admitted to the hospital. Productivity Losses Caretaker productivity loss from seeking care for a sick child was calculated by multiplying an estimate of a caretaker s daily productivity by the number of days lost due to care seeking. It was assumed that caretakers lost 50% of one day s productivity for seeking outpatient care and 100% of the total number of bed days productivity when a sick child was admitted to a hospital (See Exhibit B for a diagram of the analysis). Daily wages used in the analysis for caretaker productivity loss were based on the IMF s 2010 World Economic Outlook projected GDP per capita for the years (16) and extrapolated for years based on projected GDP per capita growth during the years These annual projections were then divided by 365 for a daily productivity estimate. To calculate productivity loss due to meningitis disability, regional ratios of survived cases that result in severe sequelae were applied to our estimated number of survived meningitis cases that would be averted (17). Age-specific survival rates 4

5 were then applied to estimate how many survivors would reach productive age and account for competing risks of mortality(18). The number of productive life years lost was then calculated by multiplying the number of children with disability that would live to productive age (age 15) by the life expectancy at age 15 and discounting it 50%. (It was assumed that severe disability, as defined by Edmond (2010) in accordance with the Global Burden of Disease - Disease Control Priorities Project, would reduce productive life years by 50% either through premature death or long-term disability.) Using the human capital approach, we multiplied the number of productive life years lost from disability by projected annual GDP/capita(16) to obtain an estimate of productivity lost due to severe meningitis sequelae. These results were discounted 3% and listed in 2009 US dollars. The same approach was used to determine productivity loss due to premature deaths. Age specific survival rates were applied to the number of averted deaths projected by LiST to calculate the number of children that would have reached productive age due to competing risks. This was then multiplied by country-specific life expectancy at age 15 to determine the number of productive life years lost due to premature death. Our estimate of productive life years lost was then multiplied by the projected 5

6 annual GDP/capita for each country. These results were discounted 3% and listed in 2009 US dollars. Sensitivity Analysis Sensitivity analyses were first conducted for key parameters associated with the LiST model. Estimated plausibility ranges around the deaths averted values were calculated for four of the largest GAVI countries (Democratic Republic of Congo, India, Nigeria and Pakistan). Confidence bounds were developed around seven parameters (mortality rates (19), cause of death (2), Hib, Pneumococcal (3) and rotavirus vaccine effectiveness (42-79%) and proportion of diarrhea deaths due to rotavirus (+- 10%)). The ratio of the upper and lower bounds to the standard value were estimated and averaged from these four countries. The ratios associated with all combinations of varying three parameters were estimated to derive a plausibility range of 30% to 297%. The next set of sensitivity analyses were conducted to present uncertainty ranges around the treatment cost savings and lost productivity estimates in the analysis. Monte Carlo simulations were carried out varying 13 key variables, such as case fatality ratios for pneumonia, meningitis, and rotavirus, productivity loss of long-term sequelae as a percentage of per capita GDP, 6

7 and the plausibility range from the LiST mortality estimates. Beta or uniform distributions were applied to each variable. See Exhibit G for baseline estimates and ranges of variables. Besides the LiST estimates, all other variables were tested for their effect on the final outcome if they were to be off by half (50%) or doubled (200%). The analysis involved running 10,000 iterations of the model using the software (version 5.7, Palisades Corporation, New Field, NY) to obtain the uncertainty ranges. See Exhibit E for the overall distribution of the cost of illness analysis. 7

8 References 1. WHO. WHO/UNICEF estimates of national immunization coverage [cited 2010 October]; Available from: eseries/tswucoveragedtp3.htm 2. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet Jun 5;375(9730): Theodoratou E, Johnson S, Jhass A, Madhi SA, Clark A, Boschi-Pinto C, et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol Apr;39 Suppl 1:i Sudfeld CR, Navar AM, Halsey NA. Effectiveness of measles vaccination and vitamin A treatment. Int J Epidemiol Apr;39 Suppl 1:i Fischer-Walker C, Black RE. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health. 2011;11(Supplement 3). 6. Olotu A, Lusingu J, Leach A, Lievens M, Vekemans J, Msham S, et al. Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and 8

9 Tanzania: a randomised controlled trial. The Lancet Infectious Diseases. 2011;11(2): UNICEF. State of the World's Children [cited 2010 November 10]; Available from: 8. MACRO. Demographic and Health Surveys, 45 countries [cited 2010 November 14]; Available from: 9. WHO. Country specific unit costs [cited 2010 November 15]; Available from: Ayieko P, Akumu AO, Griffiths UK, English M. The economic burden of inpatient paediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis. Cost Eff Resour Alloc. 2009;7: Broughton EI. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis. J Public Health (Oxf) Dec;29(4): Bassat Q, Guinovart C, Sigauque B, Aide P, Sacarlal J, Nhampossa T, et al. Malaria in rural Mozambique. Part II: children admitted to hospital. Malar J. 2008;7: Adams Iea. Malaria: A burden explored. Bulletin of Health Information. 2004;1(1): Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T. Economic and health burden of rotavirus gastroenteritis for the 9

10 2003 birth cohort in eight Latin American and Caribbean countries. Rev Panam Salud Publica Apr;21(4): Hussain H, Waters H, Omer SB, Khan A, Baig IY, Mistry R, et al. The cost of treatment for child pneumonias and meningitis in the Northern Areas of Pakistan. Int J Health Plann Manage Jul-Sep;21(3): World Economic Outlook [database on the Internet]2010 [cited November 25, 2010]. Available from: px. 17. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis May;10(5): World Health Statistics [database on the Internet]2010 [cited November 1, 2010]. Available from: Levels and Trends in Child Mortality, Report 2010 [database on the Internet]. UN Inter-agency Group on Child Mortality Estimation Available from: 10

11 EXHIBIT LIST Exhibit A. (table) Caption/headline: GAVI eligible countries (2010) Source: Exhibit B (Figure) Headline: Treatment Cost Analysis Diagram SOURCE Authors analysis. Exhibit C. (figure) Headline: Annual cost of illness averted by syndrome SOURCE Authors analysis. Exhibit D. (figure) Headline: Sensitivity analysis: Tornado diagram of input effects SOURCE Authors analysis. Exhibit E. (figure) Headline: Sensitivity analysis: Distribution of total cost of illness (72 GAVI countries) SOURCE Authors analysis. Exhibit F. (table) Headline: LiST mortality projections by disease and country Source: Johns Hopkins University. Lives Saved Tool (Version 4.2 Beta 7) Exhibit G. (table) Headline: Sensitivity analysis: Inputs and ranges SOURCE Authors analysis. Notes: *Country specific CFRs for pneumonia and meningitis were varied by multiplying them by the above weighting factor. 11

12 Exhibit A. GAVI eligible countries (2010) Afghanistan, Angola, Armenia, Azerbaijan, Bangladesh, Benin, Bhutan, Bolivia, Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic, Chad, Comoros, Democratic Republic of Congo, Republic of Congo, Cote d Ivoire, Cuba, Djibouti, Eritrea, Ethiopia, The Gambia, Georgia, Ghana, Guinea, Guinea- Bissau, Guyana, Haiti, Honduras, India, Indonesia, Kenya, Kiribati, North Korea, Kyrgyz Republic, Laos, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Moldova, Mongolia, Mozambique, Myanmar, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Papua New Guinea, Rwanda, Sao Tome and Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, Sri Lanka, Sudan, Tajikistan, Tanzania, Timor- Leste, Togo, Uganda, Ukraine, Uzbekistan, Vietnam, Yemen, Zambia, Zimbabwe 13

13 Exhibit B Treatment Cost Analysis Diagram LiST projected deaths with vaccine scale- up Difference LiST projected deaths without scale- up Deaths averted due to vaccine scale- up CFR Cases averted due to scale- up % with ARI/Fever/Diarrhea who seek care from health facility # Cases who would seek Care # Cases who wouldn t seek care Rate of admittance among all cases who seek care # Inpatients # Outpatients No Treatment Costs % outpatients seen at hospital $ per Bed Day # of Bed Days % of total for Medication & Diagnostics # of outpatients who sought care from a hospital $ per hospital outpatient % of total for Medication & Diagnostics # of outpatients who sought care from a health center $ per health center outpatient % of total for Medication & Diagnostics Treatment Costs Averted Treatment Costs Averted Treatment Costs Averted 14

14 Exhibit C. Annual Cost of Illness Averted by Syndrome 15

15 Exhibit D. Sensitivity analysis: Tornado diagram of input effects 16

16 Exhibit E. Sensitivity analysis: Distribution of total cost of illness 17

17 Exhibit F. LiST mortality projections by disease and country Baseline vaccine coverage* Deaths averted in Children < 5 years of age, by Cause, Country Pneumo- coccal Hib Rotavirus Measles DTP Malaria Pneumonia Meningitis Diarrhea Measles Pertussis Malaria Total Afghanistan ,371 12,933 90,802 4, ,209 Angola ,896 4,190 40,779 2,203 3,321 14, ,225 Armenia , ,413 Azerbaijan , ,228 Bangladesh ,827 11,781 20, ,365 96,794 Benin ,562 2,253 7, ,345 15,000 39,257 Bhutan ,897 6,567 8, ,284 Bolivia (Plurinational State of) , , ,764 Burkina Faso ,375 2,917 30, , ,731 Burundi ,938 2,126 15, ,511 38,495 Cambodia ,687 4,008 2, ,902 Cameroon ,115 6,566 26,694 3,294 1,243 32, ,390 18

18 Central African Republic ,269 1,153 6, ,660 5,264 25,347 Chad ,676 5,193 34, ,618 31, ,577 Comoros ,889 8,129 20, ,742 Congo , , ,708 13,993 Côte d'ivoire ,087 4,487 16, ,130 27,966 70,751 Cuba Democratic People's Republic of Korea , ,000 Democratic Republic of the Congo ,598 26, ,802 10,772 17, , ,112 Djibouti ,367 Eritrea , , ,866 Ethiopia ,539 14, , ,314 33, ,968 Gambia , , ,199 4,962 Georgia , ,972 Ghana ,089 1,026 6, ,146 33,488 Guinea ,521 2,657 11,184 9,675 5,573 21,137 67,747 Guinea- Bissau ,851 1,231 3, ,433 16,629 19

19 Guyana Haiti ,133 2,257 12, , ,962 Honduras , ,173 India ,925 93, , , ,732 8,828 1,449,207 Indonesia ,536 8,644 27, , ,570 Kenya ,672 4,254 28,092 2,272 1,550 15,964 84,804 Kiribati , , ,928 Kyrgyzstan , ,483 Lao People's Democratic Republic ,531 1, , ,211 Lesotho , ,194 Liberia , , ,211 10,756 Madagascar ,618 1,144 5, ,025 16,020 Malawi ,937 4,569 12, ,051 56,241 Mali ,884 2,340 26, ,005 31,287 93,865 Mauritania , , ,450 10,398 Mongolia Mozambique ,245 6,863 21, ,578 24,963 93,083 20

20 Myanmar ,424 1,837 5, ,294 Nepal ,492 2,353 5, ,384 Nicaragua , ,292 Niger ,760 7,155 38, ,414 38, ,682 Nigeria ,883 37, ,961 2,561 82, , ,154 Pakistan ,677 13,076 85, , ,052 Papua New Guinea ,527 1, , ,510 12,454 Republic of Moldova ,489 1,237 1, ,315 Rwanda ,187 2,526 14, ,071 33,496 Sao Tome and Principe ,343 6,131 10, ,162 Senegal , ,567 2, ,365 30,794 Sierra Leone ,538 1,286 11,950 5,847 1,736 7,778 43,135 Solomon Islands , ,296 Somalia ,774 4,011 20,176 21,184 12,250 6, ,737 Sri Lanka ,166 Sudan ,433 5,177 19, , ,818 Tajikistan , , ,202 21

21 Timor- Leste ,285 Togo , , ,017 16,222 Uganda ,808 10,395 45,756 15,918 18,919 69, ,045 Ukraine ,483 United Republic of Tanzania ,187 13,547 34, ,345 54, ,550 Uzbekistan , ,255 Viet Nam ,405 8,324 4, ,191 Yemen ,822 2,717 14,056 2,276 9, ,539 Zambia ,506 3,072 15, ,848 56,581 Zimbabwe ,133 1,547 3,879 5,526 3,266 1,453 23,804 Total NA NA NA NA NA NA 2,661, ,770 1,524, , ,561 1,012,123 6,374,402 22

22 Exhibit G. Sensitivity analysis: Inputs and ranges All Diseases Base Value Low (50%) High (200%) Distribution % of total bed days for meds and diagnosis Beta % of outpatients who sought care from hospital Beta % days productivity loss for caretaker of outpatient Uniform % days productivity loss for caretaker of inpatient Uniform LiST mortality range Beta Specific Diseases Base Value Low (50%) High (200%) Distribution % of GDP for productivity loss of long- term sequelae Beta Measles CFR Beta Malaria CFR Beta Pertussis CFR Beta Rotavirus CFR Beta Rotavirus India CFR Beta Pneumonia CFR Beta Weighting factor a Meningitis CFR Weighting factor a Beta a Country specific case fatality ratios for pneumonia and meningitis were varied by multiplying them by the above weighting factor 23

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook UNICEF Supply Division Update: October 2013 0 Pneumococcal Conjugate Vaccine (PCV) Supply & Demand Outlook October 2013 Update Key updates

More information

Impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries

Impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries August 29, 2018 Impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries Thirteenth International Rotavirus Symposium 29 31 August 2018 Minsk, Belarus Frédéric Debellut Health Economist,

More information

Annex 2 A. Regional profile: West Africa

Annex 2 A. Regional profile: West Africa Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262

More information

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division Rotavirus Vaccine: & Demand Update UNICEF Division July 0 Rotavirus Vaccine (RV): & Demand Update July This update provides new information on countries and their scheduled RV introductions, forecasted

More information

Eligibility List 2018

Eligibility List 2018 The Global Fund s 2017-2022 strategy and allocation-based approach enables strategic investment to accelerate the end of HIV/AIDS, tuberculosis and malaria and build resilient and sustainable systems for

More information

Update from GAVI Aurelia Nguyen

Update from GAVI Aurelia Nguyen Update from GAVI Aurelia Nguyen (Copenhagen, Denmark, 27 June 2012) GAVI vaccine support Currently supported vaccines: pentavalent, pneumococcal, rotavirus, meningitis A, human papillomavirus (HPV), rubella,

More information

VIEW-hub Report: Global Vaccine Introduction and Implementation

VIEW-hub Report: Global Vaccine Introduction and Implementation A report on current global access to new childhood vaccines VIEW-hub Report: Global Vaccine Introduction and Implementation December 2016 INTERNAL VERSION Developed from data in VIEW-hub www.view-hub.org

More information

Review of decisions Debbie Adams

Review of decisions Debbie Adams Review of decisions Debbie Adams Geneva, Switzerland, Decision 1: Board/Committee member appointments (1/3) The GAVI Alliance Board: (a) Appointed the following Board members: Joan Awunyo-Akaba as Board

More information

TT Procured by UNICEF

TT Procured by UNICEF TT TT Procured by UNICEF 2001-08 250,000,000 200,000,000 150,000,000 100,000,000 50,000,000 0 2001 2002 2003 2004 2005 2006 2007 2008 Routine SIA TT historical demand and forecast overview Upcoming Tender

More information

Global reductions in measles mortality and the risk of measles resurgence

Global reductions in measles mortality and the risk of measles resurgence Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there

More information

What is this document and who is it for?

What is this document and who is it for? Measles and Rubella Initiative s Standard Operating Procedures for Accessing Support for Measles and Rubella Supplementary Immunization Activities During 2016 In the context of measles and rubella elimination

More information

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child BCG and your baby Protecting babies against TB Immunisation the safest way to protect your child This leaflet is about the BCG (Bacillus Calmette-Guerin) vaccination that is being offered to protect your

More information

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP) COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP) Sushila Maharjan Senior Manager, Innovative Finance International Conference on Sustainable Cooling World Bank Washington DC - 29 November 2018 Reach

More information

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT UNICEF / Zar Mon Annexes EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT This report includes nine nutrition statistics, as per the 2017 Global Nutrition Report. These

More information

Rotavirus vaccines: Issues not fully addressed in efficacy trials

Rotavirus vaccines: Issues not fully addressed in efficacy trials Rotavirus vaccines: Issues not fully addressed in efficacy trials TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines Licensed in 2006

More information

Global Fund Results Fact Sheet Mid-2011

Global Fund Results Fact Sheet Mid-2011 Global Fund Results Fact Sheet Mid-2011 This fact sheet outlines some of the common questions and answers regarding results reported by Global Fund-supported programs, including the principles and approach

More information

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2 Current State of Global HIV Care Continua Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2 1) International Association of Providers of AIDS Care

More information

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2011 APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS (SEE TABLE 4.9) Africa The Americas South-East Asia Europe Eastern Mediterranean Western Pacific

More information

מדינת ישראל. Tourist Visa Table

מדינת ישראל. Tourist Visa Table Updated 23/05/2017 מדינת ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. Exe = exempted Req = required Press the first

More information

Prioritising vaccine support the GAVI perspective

Prioritising vaccine support the GAVI perspective Prioritising vaccine support the GAVI perspective Seth Berkley, M.D. CEO GAVI Alliance Fondation Mérieux 26 28 November, 2012 Mission and strategic goals 2011 2015 To save children s lives and protect

More information

Comparative Analyses of Adolescent Nutrition Indicators

Comparative Analyses of Adolescent Nutrition Indicators Comparative Analyses of Adolescent Nutrition Indicators Rukundo K. Benedict, PhD The DHS Program Stakeholders Consultation on Adolescent Girls Nutrition: Evidence, Guidance, and Gaps October 30 31, 2017

More information

CEO Board report Seth Berkley MD CEO

CEO Board report Seth Berkley MD CEO CEO Board report Seth Berkley MD CEO Dhaka, Bangladesh, 16 17 November 2011 Bangladesh, November 2011 Meningitis Incidence Children < 12 months Dhaka Shishu / Shishu Shahsta Catchment Area 2008 2011 1800

More information

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents. Updated 25/05/2015 ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. (C) Bearers of official passports requiring tourist

More information

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA Malaria Funding Richard W. Steketee MACEPA, PATH April World Malaria Day 2010, Seattle WA Malaria Funding Is there a plan? Is there money? Where does the money come from? Is the money moving efficiently?

More information

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved UNAIDS / JC2225E The designations employed and the presentation of the material in this publication

More information

Global Fund ARV Fact Sheet 1 st June, 2009

Global Fund ARV Fact Sheet 1 st June, 2009 Global Fund ARV Fact Sheet 1 st June, 2009 This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown

More information

#1 #2 OR Immunity verified by immune titer (please attach report) * No titer needed if proof of two doses of Varicella provided

#1 #2 OR Immunity verified by immune titer (please attach report) * No titer needed if proof of two doses of Varicella provided Student Information: Date of Birth: There are two ways to provide us with your immunization information. 1) Students can have their healthcare provider fill out and sign the form below. A healthcare provider

More information

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic. HEALTH & WELLNESS SERVICES INSTRUCTIONS FOR COMPLETING THE REQUIRED MEDICAL FORMS FOR: U.S. CITIZENS 18 YEARS OF AGE OR OLDER AT THE TIME THE FORMS ARE COMPLETED. THIS REQUIREMENT MUST BE COMPLETED WHETHER:

More information

Global Fund Mid-2013 Results

Global Fund Mid-2013 Results Global Fund Mid-2013 Results This fact sheet outlines some of the common questions and answers regarding results reported by Global Fund-supported programs, including the principles and approach in determining

More information

This portion to be completed by the student Return by July 1 Please use ballpoint pen

This portion to be completed by the student Return by July 1 Please use ballpoint pen This portion to be completed by the student Return by July 1 Please use ballpoint pen Start term: Fall Exploration Spring Summer Year: Class year: Freshman Sophomore Junior Senior Transfer Full name: Preferred:

More information

Certificate of Immunization

Certificate of Immunization Certificate of Immunization Required of all students (Page 1 of 5) QUESTIONS? 440-775-8180 or student.health@oberlin.edu (e-mail preferred) RETURN TO: Oberlin College Student Health Services 247 W. Lorain

More information

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control GAVI Partners Forum 4 6 December 2012, Dar es Salaam, Tanzania Maya van den Ent, MPH, UNICEF Peter Strebel,

More information

Value of post-licensure data to assess public health value Example of rotavirus vaccines

Value of post-licensure data to assess public health value Example of rotavirus vaccines Value of post-licensure data to assess public health value Example of rotavirus vaccines TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines

More information

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer SAGE meeting Geneva, 8-10 November 2011 Topics to cover Update on new vaccine introduction Introductions New approvals Co-financing

More information

Financing malaria control

Financing malaria control Chapter 6. Financing malaria control The three major sources of funds for malaria control pro - grammes are national government spending, external assistance from donors and household or private out-of-pocket

More information

HPV Vaccine Lessons Learned & New Ways Forward

HPV Vaccine Lessons Learned & New Ways Forward HPV Vaccine Lessons Learned & New Ways Forward The Gavi Alliance June 2016, Geneva www.gavi.org Overview 1 Background 2 Lessons learned 3 New Way Forward 2 1 Background 3 HPV Background HPV is responsible

More information

Gavi Unicef Vaccine Industry Consultation. Dominic Hein Market Shaping / Gavi. October Reach every child

Gavi Unicef Vaccine Industry Consultation. Dominic Hein Market Shaping / Gavi. October Reach every child Gavi Update @ Unicef Vaccine Industry Consultation Dominic Hein Market Shaping / Gavi October 2018 Reach every child www.gavi.org Gavi commitments to countries US$ 13.67 billion committed since 2001 New

More information

Maternal Deaths Disproportionately High in Developing Countries

Maternal Deaths Disproportionately High in Developing Countries EMBARGOED until Monday, 20 October, 6am GMT HQ/2003/24 20 October 2003 CF/DOC/PR/2003-82 Maternal Deaths Disproportionately High in Developing Countries African women are 175 times more likely to die in

More information

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts (charts in colour) (These charts will be updated in 2014) 2 1. Introduction 2. Instructions on how to use

More information

Vaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA

Vaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA TM Vaccines against Rotavirus & Norovirus Umesh D. Parashar CDC, Atlanta, GA 1 Rotavirus is the Leading Cause Of Severe Diarrhea in Children

More information

Disparities in access: renewed focus on the underserved. Rick Johnston, WHO UNC Water and Health, Chapel Hill 13 October, 2014

Disparities in access: renewed focus on the underserved. Rick Johnston, WHO UNC Water and Health, Chapel Hill 13 October, 2014 Disparities in access: renewed focus on the underserved Rick Johnston, WHO UNC Water and Health, Chapel Hill 13 October, 2014 Sector proposal for post-2015 targets By 2030: to eliminate open defecation;

More information

REQUIRED COLLEGIATE START. (High school students/ early entry only not for undergraduates) IMMUNIZATION FORM THIS IS REQUIRED INFORMATION

REQUIRED COLLEGIATE START. (High school students/ early entry only not for undergraduates) IMMUNIZATION FORM THIS IS REQUIRED INFORMATION REQUIRED COLLEGIATE START (High school students/ early entry only not for undergraduates) IMMUNIZATION FORM THIS IS REQUIRED INFORMATION Complete this form and return by July 1 st to: STUDENT HEALTH SERVICES

More information

FORMS MUST BE COMPLETED PRIOR TO THE START OF YOUR FIRST SEMESTER

FORMS MUST BE COMPLETED PRIOR TO THE START OF YOUR FIRST SEMESTER HEALTH & WELLNESS SERVICES INSTRUCTIONS FOR COMPLETING THE REQUIRED MEDICAL FORMS FOR: U.S. CITIZENS WHO ARE NOT 18 YEARS OF AGE AT THE TIME THE FORMS ARE COMPLETED. THIS REQUIREMENT MUST BE COMPLETED

More information

ANNEX 3: Country progress indicators

ANNEX 3: Country progress indicators : progress indicators 541 : COUNTRY PROGRESS INDICATORS 2006 REPORT ON THE GLOBAL AIDS EPIDEMIC Annex 3 : COUNTRY PROGRESS INDICATORS As of March 2006, 115 countries had reported indicators on progress

More information

UNDERGRADUATE STUDENT HEALTH PACKET

UNDERGRADUATE STUDENT HEALTH PACKET UNDERGRADUATE STUDENT HEALTH PACKET Deadlines: Fall: July 15 th Spring: December 1st Enclosed Forms/Documents: Type of Students Required For: Comments: Undergraduate Vaccine Form Physical Examination Form

More information

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i Sourcing of ARVs & HIV diagnostics Procurement for Impact P4i AMDS ANNUAL STAKEHOLDERS AND PARTNERS MEETING 29 September 2014 Global Fund: Procurement for Impact: P4i Our objective was straightforward:

More information

Scaling Up Nutrition Action for Africa

Scaling Up Nutrition Action for Africa Scaling Up Nutrition Action for Africa Where are we and what challenges are need to be addressed to accelerate malnutrition? Lawrence Haddad Global Alliance for Improved Nutrition Why should African political

More information

Vaccine Pricing: Gavi Transitioning Countries

Vaccine Pricing: Gavi Transitioning Countries Vaccine Pricing: Gavi Transitioning Countries All prices shown in this document are Unicef awarded price per dose (in USD), per product, per supplier, per calendar year, based on multi-year supply agreements.

More information

By Meghan L. Stack, Sachiko Ozawa, David M. Bishai, Andrew Mirelman, Yvonne Tam, Louis Niessen, Damian G. Walker, and Orin S.

By Meghan L. Stack, Sachiko Ozawa, David M. Bishai, Andrew Mirelman, Yvonne Tam, Louis Niessen, Damian G. Walker, and Orin S. By Meghan L. Stack, Sachiko Ozawa, David M. Bishai, Andrew Mirelman, Yvonne Tam, Louis Niessen, Damian G. Walker, and Orin S. Levine Estimated Economic Benefits During The Decade Of Vaccines Include Treatment

More information

Prioritizing Emergency Polio Eradication Activities

Prioritizing Emergency Polio Eradication Activities Prioritizing Emergency Polio Eradication Activities Managing the Financing Gap the other half of the Emergency Hamid Jafari GPEI Financing 2012-13: Budget = $2.23 b - Confirmed contributions = $1.14 b

More information

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer Strategic Advisory Group of Experts on Immunization (SAGE) Geneva, Switzerland, 1-3 April 2014 Overview Recap of recent Board decisions

More information

Health Services Immunization and Health Information

Health Services Immunization and Health Information Your complete record for required vaccines (Part II) must be on file in our Health Center before the start of classes or you will be MEDICALLY WITHDRAWN FROM CLASSES per NYS Public Health Laws 2165 and

More information

AIDS in Africa. An Update. Basil Reekie

AIDS in Africa. An Update. Basil Reekie AIDS in Africa An Update Basil Reekie Contents General Statistics The trend of HIV in Africa Ugandan experience UNAIDS 2006 Latest African Statistics by Country HIV Intervention Light at the end of the

More information

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss Mortality and Burden of Diseases and Prevention of Blindness and Deafness WHO, 2012 In 2012, WHO released

More information

Sun-Young Kim 1,2, Steven Sweet 1, Joshua Chang 1 and Sue J Goldie 1,2* Abstract

Sun-Young Kim 1,2, Steven Sweet 1, Joshua Chang 1 and Sue J Goldie 1,2* Abstract RESEARCH ARTICLE Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden Sun-Young Kim

More information

STUDENT HEALTH SERVICES NEW STUDENT QUESTIONNAIRE

STUDENT HEALTH SERVICES NEW STUDENT QUESTIONNAIRE STUDENT HEALTH SERVICES NEW STUDENT QUESTIONNAIRE UC Hastings Student Health Services (SHS) is committed to providing you the best possible medical care, so we need to know about your medical history and

More information

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia Funding for AIDS: The World Bank s Role Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia Outline New resources needs estimates Bridging the gap Global overview of

More information

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report October 2013 I N F O R M A T I O N S O U R C E S U S E D: Databases: OIE WAHID World Animal Health

More information

Global malaria mortality between 1980 and 2010: a systematic analysis

Global malaria mortality between 1980 and 2010: a systematic analysis Global malaria mortality between 1980 and 2010: a systematic analysis Christopher J L Murray, Lisa C Rosenfeld, Stephen S Lim, Kathryn G Andrews, Kyle J Foreman, Diana Haring, Nancy Fullman, Mohsen Naghavi,

More information

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations Briefing on Xpert MTB/RIF. Geneva, 21 February, 2011 Fuad Mirzayev TB Laboratory Strengthening and Diagnostics

More information

Tipping the dependency

Tipping the dependency BREAKING NEWS Meeting the investment challenge Tipping the dependency balance Domestic investments exceed international investments total reaching US$ 8.6 billion. 40 countries fund more than 70% of their

More information

all incoming UWL students MUST submit an up-to-date immunization history, including vaccination dates.

all incoming UWL students MUST submit an up-to-date immunization history, including vaccination dates. Dear Students and Parents, On behalf of the UW La Crosse Student Health Center staff, I would like to welcome you to the University and wish you a productive and healthy college career. We are looking

More information

THE CARE WE PROMISE FACTS AND FIGURES 2017

THE CARE WE PROMISE FACTS AND FIGURES 2017 THE CARE WE PROMISE FACTS AND FIGURES 2017 2 SOS CHILDREN S VILLAGES INTERNATIONAL WHERE WE WORK Facts and Figures 2017 205 58 79 families and transit 31 Foster homes 162 8 3 173 214 2 115 159 136 148

More information

STUDENT MEDICAL REPORT For Graduate and Part-time Undergraduate Students The State of Connecticut General Statutes Section 10a and Fairfield

STUDENT MEDICAL REPORT For Graduate and Part-time Undergraduate Students The State of Connecticut General Statutes Section 10a and Fairfield STUDENT MEDICAL REPORT For Graduate and Part-time Undergraduate Students The State of Connecticut General Statutes Section 10a - 155 and Fairfield University require each full-time or matriculating student

More information

O c t o b e r 1 0,

O c t o b e r 1 0, STUDENT VOICES FROM THE FIELD: WORLD HEALTH ORGANIZATION GENEVA, SWITZERLAND O c t o b e r 1 0, 2 0 1 6 M o l l y P e z z u l o University at Albany School of Public Health MPH Epidemiology Candidate 17

More information

The Immunization Record is available to download from the Health Insurance and Immunizations website at drexel.edu/hii/forms.

The Immunization Record is available to download from the Health Insurance and Immunizations website at drexel.edu/hii/forms. IMMUNIZATIONS The Immunization Record is available to download from the Health Insurance and Immunizations website at drexel.edu/hii/forms. To ensure the safety of all students, Drexel requires all full-time

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Pronyk PM, Nemser B, Maliqi B, et al, for the

More information

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA 5 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 17.1 PROGRESS REPORT ON THE ROAD MAP FOR

More information

Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions

Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions Core competencies in primary care: Supplement 2 Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions The Core competencies in

More information

Dear New Student and Family,

Dear New Student and Family, Dear New Student and Family, Enclosed is information regarding the health documents that students must (1) take to their health care provider and (2) upload prior to arriving at Moravian College. Everything

More information

Name DOB / / LAST FIRST MI Home Address: Street City: State: Zip: Name of Parent/Guardian(Emergency Contact) Relationship Contact Phone Number

Name DOB / / LAST FIRST MI Home Address: Street City: State: Zip: Name of Parent/Guardian(Emergency Contact) Relationship Contact Phone Number Page 1 of 6 OFFICE OF HEALTH SERVICES York College of PA York PA 17403-3651 (717) 849-1615 Fax: (717) 849-1601 email: healthcenter@ycp.edu DEADLINES: Fall: August 1; Spring: January 1 Name DOB / / LAST

More information

Why Invest in Nutrition?

Why Invest in Nutrition? Why Invest in Nutrition? Meera Shekar Human Development Network World Bank 2006 Three key Issues Why reducing malnutrition is essential to poverty reduction? Is malnutrition a BIG problem? How can we improve

More information

Donor Support for Contraceptives and Condoms for STI/HIV Prevention

Donor Support for Contraceptives and Condoms for STI/HIV Prevention Donor Support for Contraceptives and Condoms for STI/HIV Prevention 2001 Donor Support for Contraceptives and Condoms for STI/HIV Prevention 2001 Table of Contents List of Abbreviations and Acronyms List

More information

Comments on this bulletin are welcome. Please to Dr. Mary Agócs

Comments on this bulletin are welcome. Please  to Dr. Mary Agócs Global Invasive Bacterial Vaccine Preventable Diseases (IB-VPD) Information and Surveillance Bulletin Reporting Period: January through December 2010 Volume 4: October 2011 The World Health Organization

More information

AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries

AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries Together against Cancer The Advisory Group on Increasing Access to Radiotherapy To address the

More information

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000) Recent trends in malnutrition in developing regions 109 Annex 1 Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, ) The tables in this Annex

More information

ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD

ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD The year 2008 witnessed sustained progress in expanding access to HIV prevention, treatment and care services in low- and middle-income countries. With

More information

Global Measles and Rubella Update. April 2018

Global Measles and Rubella Update. April 2018 Global Measles and Rubella Update April 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct

More information

Aboubacar Kampo Chief of Health UNICEF Nigeria

Aboubacar Kampo Chief of Health UNICEF Nigeria Aboubacar Kampo Chief of Health UNICEF Nigeria Many thanks to UNICEF colleagues in Supply Division-Copenhagen and NY for contributing to this presentation Thirty-five countries are responsible for 98%

More information

Impact Dashboard - October 2014

Impact Dashboard - October 2014 Impact Dashboard - 2014 By 2014, PSI and its network members averted an estimated 44.2 million DALYs globally. PSI has met 60.6% of the strategic plan (SP) target to avert 198.7 million DALYs, and 56.4%

More information

MASSACHUSETTS REQUIRED IMMUNIZATION HISTORY

MASSACHUSETTS REQUIRED IMMUNIZATION HISTORY Amherst College Keefe Health Center P.O. Box 5000, Amherst, MA 01002 phone: 413.542.2267 fax: 413.542.2647 healthservice@amherst.edu STUDENT INFORMATION Last name: 2014 MASSACHUSETTS REQUIRED IMMUNIZATION

More information

ICM: Trade-offs in the fight against HIV/AIDS

ICM: Trade-offs in the fight against HIV/AIDS ICM: Trade-offs in the fight against HIV/AIDS 1 As the HIV/AIDS pandemic enters its 25 th year, both the number of infections and number of deaths due to the disease continue to rise. Despite an enormous

More information

Yellow fever Vaccine investment strategy

Yellow fever Vaccine investment strategy Yellow fever Vaccine investment strategy Background document #5 November 2013 Executive summary Since 2001, GAVI has spent ~$250M on yellow fever control $102M on routine vaccination in 17 countries ~$160M

More information

Dear New Student, Welcome to Sacred Heart University! We hope your experience here will be a healthy and happy one.

Dear New Student, Welcome to Sacred Heart University! We hope your experience here will be a healthy and happy one. Dear New Student, Welcome to Sacred Heart University! We hope your experience here will be a healthy and happy one. The State of Connecticut requires that we collect some basic health information before

More information

SEATTLE UNIVERSITY. Name. Address Street City State Zip Code. Date of Entry / Date of Birth / / School ID# M Y M D Y

SEATTLE UNIVERSITY. Name. Address Street City State Zip Code. Date of Entry / Date of Birth / / School ID# M Y M D Y SEATTLE UNIVERSITY IMMUNIZATION RECD VERIFICATION BY A HEALTH CARE PROFESSIONAL (This form is not required if you have documentation of required immunizations which can be uploaded directly to the patient

More information

IMMUNIZATION, HEALTH HISTORY, & CONSENT FORM Suffolk University Health & Wellness Services

IMMUNIZATION, HEALTH HISTORY, & CONSENT FORM Suffolk University Health & Wellness Services IMMUNIZATION, HEALTH HISTORY, & CONSENT FORM FALL/SPRING SEMESTER DEADLINE* TO RETURN COMPLETE FORMS: AUG 1 / JAN 31 *IMPORTANT! Failure to submit state-required immunization documentation will result

More information

NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Measles & Rubella Campaigns

NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Measles & Rubella Campaigns NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL Measles & Rubella Campaigns With fewer than 600 days remaining to the Millennium Development Goal (MDG) deadline,

More information

Health Insurance and Immunization Guide

Health Insurance and Immunization Guide Health Insurance and Immunization Guide INSURANCE AND IMMUNIZATIONS IMMUNIZATION POLICY Drexel University requires all entering domestic full-time undergraduate and graduate students to complete an Immunization

More information

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN 23 September 2013 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-third session Brazzaville, Republic of Congo, 2 6 September, 2013 Agenda item 14 IMMUNIZATION IN THE AFRICAN REGION: PROGRESS REPORT

More information

IMMUNIZATION VACCINES & EMERGENCIES

IMMUNIZATION VACCINES & EMERGENCIES No report No data No data IMMUNIZATION VACCINES & EMERGENCIES ROUTINE IMMUNIZATION PERFORMANCE IN THE AFRICAN REGION October 2013 issue Number of children vaccinated with the 3 rd dose of DTPcontaining

More information

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS More information about out-of-bundle charges for our small business customers calling internationally from the UK using a small business price plan Page

More information

LONDON SUMMIT ON FAMILY PLANNING, JULY 2012

LONDON SUMMIT ON FAMILY PLANNING, JULY 2012 LONDON SUMMIT ON FAMILY PLANNING, JULY 2012 Technical Note: Data sources and methodology for developing the 2012 baseline, 2020 objective, impacts and costings The UK Government and the Bill & Melinda

More information

The Prematriculation Health Status Report must be completed in its entirety prior to arriving at Allegheny College. Please PRINT legibly.

The Prematriculation Health Status Report must be completed in its entirety prior to arriving at Allegheny College. Please PRINT legibly. ALLEGHENY COLLEGE PREMATRICULATION HEALTH STATUS REPORT DEADLINE WINSLOW HEALTH CENTER JULY 1, 2016 The Prematriculation Health Status Report must be completed in its entirety prior to arriving at Allegheny

More information

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality Washington DC March 12th 2008 Professor Wendy J Graham Opinion-based decisionmaking Evidence-based decision-making

More information

Impact Dashboard - August 2014

Impact Dashboard - August 2014 Impact Dashboard - By, PSI and its network members averted an estimated 29.7 million DALYs globally. PSI has met 53.3% of the strategic plan (SP) target to avert 198.7 million DALYs, and 53.0% of the SP

More information

STUDENT HEALTH FORM *IMPORTANT DEADLINES: DUE AUGUST 1 FOR AUGUST ENTRY (FALL SEMESTER) Due January 1 for January Entry(spring semester)

STUDENT HEALTH FORM *IMPORTANT DEADLINES: DUE AUGUST 1 FOR AUGUST ENTRY (FALL SEMESTER) Due January 1 for January Entry(spring semester) Castleton University Wellness Center counseling, nursing, wellness education STUDENT HEALTH FORM *IMPORTANT DEADLINES: DUE AUGUST 1 FOR AUGUST ENTRY (FALL SEMESTER) Due January 1 for January Entry(spring

More information

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS 29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A

More information